bioRxiv · 10.1101/2024.05.08.593183
Predicting MHC-I ligands across alleles and species: How far can we go?
Abstract
CD8+ T-cell activation is initiated by the recognition of epitopes presented on class I major histocompatibility complex (MHC-I) molecules. Identifying such epitopes is useful for molecular understanding of cellular immune responses and can guide the development of personalized vaccines for various diseases including cancer. Here, we capitalize on high-quality MHC-I peptidomics data available from different species and an expanded architecture of our MHC-I ligand predictor (MixMHCpred) to carefully explore how much predictions can be extrapolated to MHC-I alleles without known ligands. Our results reveal high prediction accuracy for most MHC-I alleles in human and in laboratory mouse strains, but significantly lower accuracy in other species. Our work further outlines some of the molecular determinants of MHC-I ligand predictions accuracy across alleles and species. Robust benchmarking on external data shows that the pan-allele version of MixMHCpred (v3.0) outperforms other state-of-the-art MHC-I ligand predictors and can be used for CD8+ T-cell epitope predictions.
Source connections
Explore related subjects
Keep this discovery
Explore connections, maps & timelines
Tadros, D. M., Racle, J., Gfeller, D.. 2024-05-10. Predicting MHC-I ligands across alleles and species: How far can we go?. https://doi.org/10.1101/2024.05.08.593183
Cite the original work for its findings. Save a collection to share your selection of sources.